NPCE (NeuroPace, Inc.) Stock Financials & Earnings

NPCENeuroPace, Inc.

Mkt Cap$482M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$100M

Net Income (TTM)-$32M

EPS (TTM)-$0.66

Free Cash Flow (TTM)-$11M

Gross Margin77.2%

Op. Margin-16.3%

Net Margin-31.9%

FCF Margin-11.2%

P/S Ratio (TTM)4.8x

P/E Ratio (TTM)—

YoY Rev Growth+25.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$14M	$10M	-$8M
Q2 23	$17M	$12M	-$8M
Q3 23	$16M	$12M	-$6M
Q4 23	$18M	$14M	-$5M
Q1 24	$18M	$13M	-$8M
Q2 24	$19M	$14M	-$6M
Q3 24	$21M	$15M	-$4M
Q4 24	$21M	$16M	-$4M
Q1 25	$23M	$17M	-$5M
Q2 25	$24M	$18M	-$7M
Q3 25	$27M	$21M	-$3M
Q4 25	$27M	$21M	-$2M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$5M	—	—	$13M
Q2 23	$5M	—	—	$14M
Q3 23	$5M	—	—	$13M
Q4 23	$5M	—	—	$13M
Q1 24	$6M	—	—	$15M
Q2 24	$6M	$5M	$10M	—
Q3 24	$6M	—	—	$14M
Q4 24	$6M	—	—	$14M
Q1 25	$7M	—	—	$15M
Q2 25	$7M	$6M	$12M	—
Q3 25	$7M	$5M	$13M	—
Q4 25	$7M	$336K	—	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$7M	$61M	$68M
Q2 23	$8M	$56M	$64M
Q3 23	$10M	$52M	$61M
Q4 23	$18M	$48M	$66M
Q1 24	$13M	$46M	$59M
Q2 24	$13M	$43M	$56M
Q3 24	$15M	$41M	$57M
Q4 24	$13M	$39M	$53M
Q1 25	$27M	$39M	$66M
Q2 25	$23M	$39M	$62M
Q3 25	$21M	$39M	$60M
Q4 25	$22M	$39M	$61M

Shares Outstanding

Revenue Per Employee

Revenue / Employee